{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T20:44:24Z","timestamp":1774817064554,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41585-023-00788-1","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T09:02:33Z","timestamp":1685955753000},"page":"522-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Doxycycline-PEP \u2014 novel and promising but needs monitoring"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-2081","authenticated-orcid":false,"given":"Magnus","family":"Unemo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-3080","authenticated-orcid":false,"given":"Fabian Yuh Shiong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"788_CR1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016\u20132021: actions for impact (WHO, 2021)."},{"key":"788_CR2","doi-asserted-by":"publisher","first-page":"E528","DOI":"10.1016\/S2468-2667(21)00112-2","volume":"6","author":"BR Bavinton","year":"2021","unstructured":"Bavinton, B. R. & Grulich, A. E. HIV pre-exposure prophylaxis: scaling up for impact now and in the future. Lancet Public Health 6, E528\u2013E533 (2021).","journal-title":"Lancet Public Health"},{"key":"788_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","volume":"18","author":"J-M Molina","year":"2018","unstructured":"Molina, J.-M. et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect. Dis. 18, 308\u2013317 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"788_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","volume":"388","author":"AF Luetkemeyer","year":"2023","unstructured":"Luetkemeyer, A. F. et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N. Engl. J. Med. 388, 1296\u20131306 (2023).","journal-title":"N. Engl. J. Med."},{"key":"788_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/antibiotics9100656","volume":"9","author":"MA Fiore","year":"2020","unstructured":"Fiore, M. A., Raisman, J. C., Wong, N. H., Hudson, A. O. & Wadsworth, C. B. Exploration of the Neisseria resistome reveals resistance mechanisms in commensals that may be acquired by N. gonorrhoeae through horizontal gene transfer. Antibiotics 9, 656 (2020).","journal-title":"Antibiotics"},{"key":"788_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad129","author":"FYS Kong","year":"2023","unstructured":"Kong, F. Y. S., Kenyon, C. & Unemo, M. Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections. J. Antimicrob. Chemother. https:\/\/doi.org\/10.1093\/jac\/dkad129 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"788_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"788_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001810","author":"T Vanbaelen","year":"2023","unstructured":"Vanbaelen, T., Manoharan-Basil, S. S. & Kenyon, C. Doxycycline post exposure prophylaxis could induce cross-resistance to other classes of antimicrobials in Neisseria gonorrhoeae: an in-silico analysis. Sex. Transm. Dis. https:\/\/doi.org\/10.1097\/OLQ.0000000000001810 (2023).","journal-title":"Sex. Transm. Dis."},{"key":"788_CR9","unstructured":"Traeger, M. et al. Potential impact and efficiency of doxy-PEP among people with or at risk of HIV. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI) (2023)."},{"key":"788_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad279","author":"TD Mortimer","year":"2023","unstructured":"Mortimer, T. D. & Grad, Y. H. A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciad279 (2023).","journal-title":"Clin. Infect. Dis."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00788-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T13:05:53Z","timestamp":1693573553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00788-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1038\/s41585-023-00788-1","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"5 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}